Use of a vesicular stomatitis virus complementation system to analyze respiratory syncytial virus binding (Q40686662)

22 September 2017

Use of a vesicular stomatitis virus complementation system to analyze respiratory syncytial virus binding (English)

1 reference

22 September 2017

1 reference

Kaci Klenk

1

1 reference

PubMed ID

12457986

22 September 2017

Sharon R Roberts

series ordinal

2

1 reference

22 September 2017

1 December 2002

1 reference

22 September 2017

1 reference

22 September 2017

90

1 reference

22 September 2017

1-2

1 reference

22 September 2017

327-335

1 reference

Direct observation of the budding and fusion of an enveloped virus by video microscopy of viable cells

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for va

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Active respiratory syncytial virus purified by ion-exchange chromatography: characterization of binding and elution requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Purification of human respiratory syncytial virus: superiority of sucrose gradient over percoll, renografin, and metrizamide gradients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Efficient selection for high-expression transfectants with a novel eukaryotic vector

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Fusion glycoprotein of human parainfluenza virus type 3: nucleotide sequence of the gene, direct identification of the cleavage-activation site, and comparison with other paramyxoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

A system for functional analysis of Ebola virus glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

Functional importance of the coiled-coil of the Ebola virus glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900250-2

7 January 2021

10.1016/S0168-1702(02)00250-2

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

12457986